OptimizeRx Corporation logo OPRX - OptimizeRx Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 11
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $10.50 DETAILS
HIGH: $14.00
LOW: $7.00
MEDIAN: $10.50
CONSENSUS: $10.50
UPSIDE: 112.55%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Revenue
Revenue 109.4 92.1 71.5 62.5 61.3 43.3 24.6 21.2 12.1 7.8 7.2 6.5 5.0 2.0 1.1 0.1 0.0 0.1 0.1
Cost of Revenue 40.2 32.7 28.6 23.5 25.7 19.2 9.2 9.0 6.2 3.4 3.6 3.2 1.8 0.1 0 0 2.6 0 0
Gross Profit 69.3 59.4 42.9 39.0 35.6 24.1 15.4 12.2 6.0 4.3 3.6 3.3 3.2 1.9 1.1 0.1 (2.6) 0.1 0.1
Operating Expenses
R&D Expenses 0 0 0 0 0 0 1.6 0.7 1.0 0.4 0.3 0.2 0.1 0.1 0 0.1 0 0 0
SG&A Expenses 50.2 61.3 58.0 49.2 33.2 19.9 14.4 10.3 6.7 5.2 3.3 3.5 2.8 2.2 2.6 1.7 2.4 0 0
Other Expenses 7.0 11.8 11.3 2.0 2.1 6.3 3.2 0.4 0.3 0.2 0.6 0.3 0.2 0.2 0 0.1 0.3 1.6 0.5
Operating Expenses 57.2 73.1 69.3 51.3 35.3 26.2 19.1 12.0 8.1 5.9 4.2 3.9 3.0 2.4 2.6 1.9 2.7 1.6 0.5
Operating Income
Operating Income 12.1 (13.7) (26.4) (12.3) 0.4 (2.1) (3.7) 0.2 (2.1) (1.6) (0.6) (1.0) 0.2 (0.4) (1.5) (1.8) (2.6) (1.5) (0.4)
Interest Expense 5.3 6.2 1.5 0 0 0 0 0 0 0 0 0 0 0.0 1.0 0.1 0.0 0.0 0.0
Interest Income 0.4 0.3 2.2 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Profitability
EBITDA 16.4 (8.9) (21.3) (9.4) 2.3 0.6 (1.5) 1.2 (1.8) (1.3) (0.3) (0.8) 0.4 (0.3) (1.0) (1.8) (4.5) (4.2) (0.4)
EBIT 12.1 (13.2) (23.7) (11.4) 0.4 (1.3) (2.7) 0.8 (2.1) (1.5) (0.6) (1.0) 0.2 (0.5) (1.2) (1.9) (4.6) (4.2) (0.4)
Income Before Tax 7.0 (19.4) (25.2) (11.4) 0.4 (2.2) (2.2) 0.2 (2.1) (1.5) (0.6) (1.0) 0.2 (0.4) (2.1) (2.0) (4.6) (4.2) (0.4)
Income Tax Expense 1.8 0.7 (7.6) 0 0 0 0.9 0 0 0 0.0 0 0.0 0.0 0 0.2 0.0 0.0 0
Net Income 5.1 (20.1) (17.6) (11.4) 0.4 (2.2) (3.1) 0.2 (2.1) (1.5) (0.6) (1.0) 0.2 (0.4) (2.1) (2.0) (4.6) (4.2) (0.4)
Per Share Data
EPS (Basic) 0.28 -1.10 -1.03 -0.64 0.02 -0.15 -0.23 0.02 -0.21 -0.16 -0.07 -0.14 -0.06 -0.08 -0.46 -0.46 -1.09 -1.06 -0.10
EPS (Diluted) 0.27 -1.10 -1.03 -0.64 0.02 -0.15 -0.23 0.02 -0.21 -0.16 -0.07 -0.14 -0.06 -0.08 -0.46 -0.46 -1.09 -1.06 -0.10
Shares Outstanding 18.6 18.3 17.1 17.8 17.2 14.8 13.4 11.3 9.8 9.9 8.2 7.5 4.8 4.7 4.6 4.4 4.2 4.0 3.5
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008
Current Assets
Cash & Cash Equivalents 23.4 13.4 13.9 18.2 84.7 10.5 18.9 8.9 5.1 7.0 0.7 2.5
Short-Term Investments 0 0 0 55.9 0 0 0 0 0 0 0 0
Net Receivables 37.8 38.2 37.3 22.2 24.8 17.9 7.4 6.5 3.4 3.1 0.0 0.0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0.8 0.4 0.4 0.5 0.6 0 0 0 0 0 0 0
Total Current Assets 64.7 54.0 54.3 98.6 115.1 32.9 27.1 16.0 8.8 10.2 0.7 2.5
Non-Current Assets
Property, Plant & Equipment 0.5 0.5 0.7 0.4 0.5 0.6 0.7 0.1 0.2 0.2 0.0 0.0
Goodwill 70.9 70.9 78.4 22.7 14.7 14.7 14.7 3.7 0 0 0 0
Intangible Assets 40.8 45.5 49.4 13.0 10.6 12.1 13.9 5.3 0.8 1.1 0.2 0.1
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0.0 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0 0
Total Non-Current Assets 112.2 117.2 129.0 36.1 25.9 27.5 29.5 9.1 1.0 1.3 0.2 0.1
Total Assets 176.9 171.2 183.4 134.7 141.0 60.3 56.6 25.1 9.8 11.5 0.9 2.6
Current Liabilities
Account Payables 1.6 2.2 2.2 1.5 0.6 0.6 0.5 0.4 0.5 0.4 0.0 0.2
Short-Term Debt 4.4 2 2 0 0 0 0 0 0 0 0 0.0
Deferred Revenue 0.5 0.5 0.2 0.2 1.4 0.3 0.6 0.6 0.5 0.4 0 (0.0)
Other Current Liabilities 14.7 0 5.6 0 0 0 0 1.9 0 0 0 0
Total Current Liabilities 21.3 18.7 17.9 8.4 9.4 10.0 6.1 4.2 3.5 3.7 0.0 0.2
Non-Current Liabilities
Long-Term Debt 21.4 30.8 34.2 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 5.7 4.5 4.3 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 5.2 2.4 0 0 0 0
Total Non-Current Liabilities 27.4 35.5 38.9 0.1 0.2 0.3 5.7 2.4 2.6 2.9 0 0
Total Liabilities 48.6 54.2 56.8 8.5 9.6 10.4 11.8 6.6 3.5 3.7 0.0 0.2
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (79.2) (84.4) (64.3) (46.7) (35.3) (35.6) (33.4) (30.3) (30.4) (28.3) (19.0) (14.5)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 (0.1) (0.1) (0.0) (0.0) (0.0)
Total Stockholders' Equity 128.3 117.0 126.6 126.1 131.4 50.0 44.9 18.5 6.2 7.8 0.9 2.4
Total Liabilities & Equity 176.9 171.2 183.4 134.7 141.0 60.3 56.6 25.1 9.8 11.5 0.9 2.6
Debt Metrics
Total Debt 26.1 33.2 36.8 0.2 0.3 0.4 0.6 0 0 0 0 0.0
Net Debt 2.7 19.8 23.0 (18.0) (84.4) (10.1) (18.3) (8.9) (5.1) (7.0) (0.7) (2.5)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income 5.1 (20.1) (17.6) (11.4) 0.4 (2.2) (3.1) 0.2 (2.1) (1.5)
Depreciation & Amortization 4.3 4.3 2.4 2.0 2.0 2.1 1.3 0.3 0.3 0.2
Stock-Based Compensation 7.0 11.5 13.7 15.7 5.5 3.2 2.3 1.9 0.1 0.2
Change in Working Capital 0.8 0.9 (15.6) 4.0 (7.2) (9.7) (1.8) (2.3) (0.7) 0.3
Other Non-Cash Items 0.3 6.8 9.8 0.4 0.1 0.1 0.6 0.7 0.8 0.4
Operating Cash Flow 18.7 4.9 (7.2) 10.7 0.7 (6.3) (1.7) 0.8 (1.5) (0.5)
Investing Activities
Capital Expenditure (0.1) (0.1) (0.9) (0.2) (0.5) (0.1) (1.6) (0.1) (0.0) (0.3)
Acquisitions 0 0 (80.4) (2) 0 0 (9.0) (5.6) 0 0
Purchases of Investments 0 0 (162.8) (55.9) 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 218.7 0 0 0 0 0 0 0
Other Investing Activities 0.1 (0.3) (0.8) (0.2) (0.4) (0.1) 0 (0.1) 0 (0.2)
Investing Cash Flow 0.1 (0.5) (25.3) (58.2) (0.5) (0.1) (10.6) (5.7) (0.0) (0.3)
Financing Activities
Net Debt Issuance (8) (4) 36.0 0 0 0 0 0 0 0
Stock Repurchased 0 (0.9) (7.5) (20.0) 0 0 0 0 (0.4) (0.8)
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (1.1) 0 (0.3) 1.1 3.3 (4.4) 0.9 0.5 0 0
Financing Cash Flow (8.8) (4.9) 28.2 (19.0) 73.9 (1.9) 22.2 8.7 (0.4) (0.4)
Cash Position
Net Change in Cash 10.0 (0.5) (4.4) (66.5) 74.2 (8.3) 9.9 3.8 (1.9) (1.2)
Cash at Beginning 13.4 13.9 18.2 84.7 10.5 18.9 8.9 5.1 7.0 8.2
Cash at End 23.4 13.4 13.9 18.2 84.7 10.5 18.9 8.9 5.1 7.0
Free Cash Flow 18.7 4.8 (8.1) 10.4 0.2 (6.4) (3.2) 0.7 (1.5) (0.8)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Income Statement
Revenue 109.4 92.1 71.5 62.5 61.3 43.3 24.6 21.2 12.1 7.8 7.2 6.5 5.0 2.0 1.1 0.1 0.0 0.1 0.1
Gross Profit 69.3 59.4 42.9 39.0 35.6 24.1 15.4 12.2 6.0 4.3 3.6 3.3 3.2 1.9 1.1 0.1 (2.6) 0.1 0.1
Operating Income 12.1 (13.7) (26.4) (12.3) 0.4 (2.1) (3.7) 0.2 (2.1) (1.6) (0.6) (1.0) 0.2 (0.4) (1.5) (1.8) (2.6) (1.5) (0.4)
Net Income 5.1 (20.1) (17.6) (11.4) 0.4 (2.2) (3.1) 0.2 (2.1) (1.5) (0.6) (1.0) 0.2 (0.4) (2.1) (2.0) (4.6) (4.2) (0.4)
EPS (Diluted) 0.27 -1.10 -1.03 -0.64 0.02 -0.15 -0.23 0.02 -0.21 -0.16 -0.07 -0.14 -0.06 -0.08 -0.46 -0.46 -1.09 -1.06 -0.10
Balance Sheet
Cash & Equivalents 23.4 13.4 13.9 18.2 84.7 10.5 18.9 8.9 5.1 7.0 0.7 2.5
Total Assets 176.9 171.2 183.4 134.7 141.0 60.3 56.6 25.1 9.8 11.5 0.9 2.6
Total Debt 26.1 33.2 36.8 0.2 0.3 0.4 0.6 0 0 0 0 0.0
Stockholders' Equity 128.3 117.0 126.6 126.1 131.4 50.0 44.9 18.5 6.2 7.8 0.9 2.4
Cash Flow
Operating Cash Flow 18.7 4.9 (7.2) 10.7 0.7 (6.3) (1.7) 0.8 (1.5) (0.5)
Capital Expenditure (0.1) (0.1) (0.9) (0.2) (0.5) (0.1) (1.6) (0.1) (0.0) (0.3)
Free Cash Flow 18.7 4.8 (8.1) 10.4 0.2 (6.4) (3.2) 0.7 (1.5) (0.8)